We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
374 hedge funds and large institutions have $14B invested in Alnylam Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 124 increasing their positions, 125 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
57% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 37
5% more funds holding
Funds holding: 356 → 374 (+18)
8% more call options, than puts
Call options by funds: $130M | Put options by funds: $120M
0.57% less ownership
Funds ownership: 93.55% → 92.99% (-0.57%)
1% less repeat investments, than reductions
Existing positions increased: 124 | Existing positions reduced: 125
11% less capital invested
Capital invested by funds: $15.8B → $14B (-$1.74B)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
374
Holders Change
+18
Holders Change %
+5.06%
% of All Funds
6.62%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.11%
New
58
Increased
124
Reduced
125
Closed
37
Calls
$130M
Puts
$120M
Net Calls
+$9.54M
Net Calls Change
+$19.3M
